Practical guidance for the diagnosis and management of functional abdominal cramping pain
Country and language selection
FACP definition (with or without FGID) and diagnosis
The expert panel suggested a definition for FACP as “the sudden occurrence of mild-to-moderate, undulating, and recurring cramping pain in any part of the abdomen, lasting for seconds to minutes or up to a few hours, in the absence of any ‘red flag’ signs/symptoms of structural organic disease or any strong association with defecation (which might indicate IBS), and typically not significantly interfering with daily activities” [3].
For FACP diagnosis, it is recommended to initially recognise and exclude ‘red flags’ (alarm symptoms) (Fig. 1) indicative for a structural organic disease, followed by a detailed investigation of family history, medication, pain characteristics and dietary/defecation habits. Physical examination, laboratory tests, psychosocial assessment and abdominal ultrasound may be required in some cases.
Fig. 1. Frequent red flags that may be present in patients with FACP requiring specialist referral [3]. FACP: functional abdominal cramping pain; GI disease: gastrointestinal disease; IBD: inflammatory bowel disease
Management recommendations for FACP
The algorithm suggested for physicians’ use focuses on the optimal diagnosis and management of FACP in a primary care setting. The recommendations suggested for pharmacists and patients (Fig. 2) support raising awareness for ‘red flag’ symptoms and highlight alternative treatment approaches and may serve as a source of education for pharmacists and patients thus enabling effective self-management of FACP.
Fig. 2. Recommendations for the symptomatic management of FACP by pharmacists, as well as for patient self-care. FACP: functional abdominal cramping pain; IBS: irritable bowel syndrome
Summary
Literature
- Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil. 2017;23:151–63. doi: 10.5056/jnm16214.
- Drossman DA. Functional gastrointestinal disorders: History, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016;150:1262–79.e2. doi: 10.1053/j.gastro.2016.02.032.
- Müller-Lissner S, Andresen V, et al. Functional abdominal cramping pain; expert practical guidance. J Clin Gastroenterol. 2022;56(10):844–52. doi: 10.1097/MCG.0000000000001764. Epub 2022 Sep 23.
- Black CJ, Drossman DA, et al. Functional gastrointestinal disorders: Advances in understanding and management. Lancet. 2020;396:1664–74. doi: 10.1016/S0140-6736(20)32115-2. Epub 2020 Oct 10.
- Barbara G, Feinle-Bisset C, et al. The intestinal microenvironment and functional gastrointestinal disorders. Gastroenterology. 2016;150:1305–18. doi: 10.1053/j.gastro.2016.02.028.
- Ford AC, Sperber AD, et al. Irritable bowel syndrome. Lancet. 2020;396:1675–88. doi: 10.1016/S0140-6736(20)31548-8. Epub 2020 Oct 10.
- Pellissier S, Bonaz B. The place of stress and emotions in the irritable bowel syndrome. Vitam Horm. 2017;103:327–54. doi: 10.1016/bs.vh.2016.09.005. Epub 2016 Nov 23.
Acknowledgements: The authors thank Paula Fontanilla, PhD, for critically reviewing the scientific content of this manuscript and Debayan Goswami, an employee of Sanofi, for providing writing and editorial support.
Conflict of interest: D. Marquez, H. Weigmann and R. Lange are employees of Sanofi.
Disclosure: Sanofi funded medical writing and publication of this manuscript.